SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-22-007660
Filing Date
2022-11-25
Accepted
2022-11-25 16:30:18
Documents
12
Period of Report
2022-11-18
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_112522.htm   iXBRL 8-K 21380
  Complete submission text file 0001171843-22-007660.txt   192174

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE apto-20221118.xsd EX-101.SCH 3203
3 XBRL LABEL FILE apto-20221118_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE apto-20221118_pre.xml EX-101.PRE 22343
6 EXTRACTED XBRL INSTANCE DOCUMENT f8k_112522_htm.xml XML 3594
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32001 | Film No.: 221420447
SIC: 2836 Biological Products, (No Diagnostic Substances)